Ftse Mib
34.917,53
0,39%
DAX
20.339,45
0,64%
S&P 500
5.947,51
-0,47%
NASDAQ
19.685,44
-0,90%
Bitcoin
98.221,03
-3,97%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ FibroGen Inc (FGEN) FibroGen Inc (FGEN) Notizie

FibroGen Inc

FGEN
0,6568
-0,0102 (-1,53%)
Ultimo aggiornamento: 17:28:52
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
18/12/202423:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
16/12/202415:15EDGAR2Form 8-K - Current report
16/12/202414:05GLOBEFibroGen Appoints David DeLucia as Chief Financial Officer
10/12/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/12/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/12/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202422:52EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
12/11/202422:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202422:05EDGAR2Form 8-K - Current report
12/11/202422:05GLOBEFibroGen Reports Third Quarter 2024 Financial Results
04/11/202422:05GLOBEFibroGen to Report Third Quarter 2024 Financial Results
03/10/202422:05EDGAR2Form 8-K - Current report
16/9/202422:05EDGAR2Form 8-K - Current report
13/9/202422:12EDGAR2Form 8-K - Current report
10/9/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/9/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/9/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202422:11EDGAR2Form 8-K - Current report
03/9/202422:05GLOBEFibroGen to Present at the H.C. Wainwright 26th Annual..
07/8/202423:10EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/8/202423:05EDGAR2Form 8-K - Current report
06/8/202422:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/8/202422:05EDGAR2Form 8-K - Current report
06/8/202422:05GLOBEFibroGen Reports Second Quarter 2024 Financial Results and..
05/8/202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/7/202422:07GLOBEFibroGen to Report Second Quarter 2024 Financial Results
30/7/202422:05GLOBEFibroGen Announces Topline Results from Two Late-Stage..
11/7/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
08/7/202422:32EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
18/6/202414:00GLOBEFibroGen to Host Part II of Virtual KOL Investor Event..
13/6/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202400:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/6/202401:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/6/202401:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202422:12EDGAR2Form 8-K - Current report
07/6/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202422:05GLOBEFibroGen Announces Clinical Trial Supply Agreement with..
03/6/202422:02GLOBEFibroGen Announces FDA Clearance of Investigational New Drug..
03/6/202413:00GLOBEFibroGen to Present at Goldman Sachs 45th Annual Global..
23/5/202423:05GLOBEFibroGen Announces Presentation of Positive Interim Data..
07/5/202417:55APSTraders Rush To Buy Biotech Following Q1 Earnings Beat
07/5/202413:00GLOBEFibroGen to Participate in Upcoming Investor Conferences
06/5/202422:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/5/202422:05EDGAR2Form 8-K - Current report
06/5/202422:02GLOBEFibroGen Reports First Quarter 2024 Financial Results
Apertura: 0,68 Min: 0,64 Max: 0,755
Chiusura: 0,667

La tua Cronologia

NASDAQ
FGEN
FibroGen
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network